By analyzing 85 patients with advanced cancers such as lung, kidney, and melanoma, we discovered that high levels of GDF-15 were associated with worse survival outcomes and a higher likelihood of cancer-related cachexia, a condition causing severe weight and muscle loss. Here, GDF15 is linked to cancer.